BioCentury
ARTICLE | Distillery Therapeutics

Cancer

January 11, 2017 12:54 AM UTC

Patient sample, cell culture and mouse studies suggest inhibiting the long non-coding RNA (lncRNA) TUG1 could help treat glioblastoma multiforme (GBM). In tissue samples from patients, levels of TUG1 ...

BCIQ Company Profiles

Nagoya University